Showing results (71-80 of 905) with videos related to
Sort By:
Pageof 91
Circulation. Heart Failure|November 25, 2024
Mineralocorticoid Receptor Antagonists in Heart Failure: An UpdateJoão Pedro Ferreira, Bertram Pitt, Faiez ZannadThe Lancet. Healthy Longevity|September 13, 2022
Histone deacetylase inhibitors for cardiovascular conditions and healthy longevityJoão Pedro Ferreira, Bertram Pitt, Faiez ZannadHypertension (Dallas, Tex. : 1979)|June 11, 2020
Mineralocorticoid Receptor Antagonists for Hypertension Management in Advanced Chronic Kidney Disease: BLOCK-CKD TrialGeorge Bakris, Y Fred Yang, Bertram PittEuropean Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Mineralocorticoid receptor antagonists in patients with heart failure: current experience and future perspectivesBertram Pitt, João Pedro Ferreira, Faiez ZannadKidney International. Supplement|October 16, 2004
Cardiovascular risk in chronic kidney diseaseNagesh S Anavekar, Marc A PfefferAmerican Journal of Physiology. Heart and Circulatory Physiology|July 11, 2006
Improvements in clinical outcomes with the use of angiotensin-converting enzyme inhibitors: cross-fertilization between clinical and basic investigationMarc A Pfeffer, Edward D FrohlichNature Reviews. Cardiology|September 5, 2012
The many faces of heart failure with preserved ejection fractionAmil M Shah, Marc A PfefferNEJM Evidence|February 6, 2024
Clinical Translation of Cardiovascular Biomarkers - A Long and Uncertain RoadJonathan W Cunningham, Marc A PfefferJACC. Heart Failure|April 4, 2016
QRS Duration Is a Predictor of Adverse Outcomes in Heart Failure With Preserved Ejection FractionJacob Joseph, Brian C Claggett, Inder S Anand, et al.Journal of Cardiac Failure|May 31, 2022
Prognostic Impact of Cardiovascular Versus Noncardiovascular Hospitalizations in Heart Failure With Preserved Ejection Fraction: Insights From TOPCATEbrahim Barkoudah, Brian L Claggett, Eldrin F Lewis, et al.Pageof 91